AG2R LA Mondiale Gestion D Actifs Acquires New Stake in Elevance Health, Inc. $ELV

Key Points

• AG2R LA Mondiale Gestion D Actifs has acquired a new stake in Elevance Health, purchasing 8,733 shares valued at approximately $3,799,000 in the first quarter.
• A number of large investors have increased their holdings in Elevance Health during the fourth quarter, including MIRAE ASSET GLOBAL which raised its stake by 8.1% to own 39,815 shares worth $14.68 million.
• Elevance Health recently announced a quarterly dividend of $1.71 per share, representing an annualized dividend yield of 2.2%, with a payout ratio of 29.11%.

AG2R LA Mondiale Gestion D Actifs acquired a new stake in Elevance Health, Inc. (NYSE:ELV - Free Report) during the first quarter, according to its most recent filing with the SEC. The firm acquired 8,733 shares of the company's stock, valued at approximately $3,799,000.

A number of other large investors have also modified their holdings of ELV. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Elevance Health by 8.1% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 39,815 shares of the company's stock worth $14,688,000 after buying an additional 2,991 shares in the last quarter. Numerai GP LLC purchased a new stake in shares of Elevance Health during the 4th quarter worth $767,000. NorthRock Partners LLC boosted its position in shares of Elevance Health by 121.1% during the 4th quarter. NorthRock Partners LLC now owns 2,067 shares of the company's stock worth $763,000 after purchasing an additional 1,132 shares in the last quarter. Nomura Holdings Inc. boosted its position in shares of Elevance Health by 168.8% during the 4th quarter. Nomura Holdings Inc. now owns 8,335 shares of the company's stock worth $3,075,000 after purchasing an additional 5,234 shares in the last quarter. Finally, Mufg Securities Americas Inc. purchased a new stake in shares of Elevance Health during the 4th quarter worth $1,263,000. 89.24% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Elevance Health

In related news, Director Susan D. Devore acquired 1,200 shares of the company's stock in a transaction dated Tuesday, August 19th. The stock was bought at an average price of $312.15 per share, with a total value of $374,580.00. Following the purchase, the director directly owned 3,502 shares in the company, valued at $1,093,149.30. The trade was a 52.13% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Gail Boudreaux bought 8,500 shares of Elevance Health stock in a transaction that occurred on Friday, July 18th. The stock was purchased at an average price of $286.94 per share, for a total transaction of $2,438,990.00. Following the acquisition, the chief executive officer directly owned 151,020 shares of the company's stock, valued at $43,333,678.80. The trade was a 5.96% increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 0.29% of the company's stock.

Analyst Ratings Changes

ELV has been the topic of several research analyst reports. Wells Fargo & Company decreased their target price on shares of Elevance Health from $400.00 to $330.00 and set an "overweight" rating on the stock in a research report on Friday, August 15th. Leerink Partnrs lowered shares of Elevance Health from a "strong-buy" rating to a "hold" rating in a research report on Thursday, July 17th. Argus restated a "hold" rating on shares of Elevance Health in a research report on Monday, July 21st. Barclays boosted their target price on shares of Elevance Health from $327.00 to $373.00 and gave the stock an "overweight" rating in a research report on Thursday, September 4th. Finally, Royal Bank Of Canada reiterated an "outperform" rating and issued a $478.00 price objective on shares of Elevance Health in a research report on Wednesday, June 4th. Twelve equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $411.06.

Elevance Health Price Performance

Shares of NYSE:ELV opened at $314.34 on Friday. The business's fifty day moving average price is $307.25 and its two-hundred day moving average price is $371.33. The stock has a market cap of $70.78 billion, a PE ratio of 13.38, a price-to-earnings-growth ratio of 1.12 and a beta of 0.59. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.44 and a current ratio of 1.44. Elevance Health, Inc. has a one year low of $273.71 and a one year high of $559.95.

Elevance Health (NYSE:ELV - Get Free Report) last released its earnings results on Thursday, July 17th. The company reported $8.84 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $9.30 by ($0.46). The firm had revenue of $49.42 billion during the quarter, compared to analysts' expectations of $48.26 billion. Elevance Health had a net margin of 2.83% and a return on equity of 17.59%. Elevance Health's revenue for the quarter was up 14.3% on a year-over-year basis. During the same quarter last year, the company posted $10.12 earnings per share. On average, analysts forecast that Elevance Health, Inc. will post 33.96 EPS for the current fiscal year.

Elevance Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Wednesday, September 10th will be paid a dividend of $1.71 per share. The ex-dividend date of this dividend is Wednesday, September 10th. This represents a $6.84 dividend on an annualized basis and a dividend yield of 2.2%. Elevance Health's dividend payout ratio is currently 29.11%.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.

Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.